Anti-tumour necrosis factor-alpha (anti-TNFα) therapy had been a proven strategy for treating inflammatory bowel disease, where TNFα-binding lactococci bacterium can also act as infrared fluorescent protein. Here, TNF is linked to inflammatory bowel disease.